2- (4-Isobutylphenyl) -propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance
Viara, M.
Minerva Medica 64(47): 2513-2514
1973
ISSN/ISBN: 0026-4806 PMID: 4579843 Document Number: 60517
Document emailed within 1 workday
Related Documents
Menarini, C.; Ferri, S.; Pazzaglia Minghetti, B. 1973: Our experience in the treatment of rheumatic diseases with 2-(4-isobutylphenyl)-propionic acid Minerva Medica 64(47): 2503-2506Venerando, A.; Santilli, G. 1973: Use of 2-(4-isobutylphenyl)-propionic acid (brufen) in the treatment of some diseases of athletes Minerva Medica 64(48): 2537-2539
Alessandrini, A.; Gemini, R. 1980: Comparative clinical study of the efficacy of and tolerance for lysine para-isobutylphenyl propionate in parallel with indomethacin and pyrasanone La Clinica Terapeutica 94(2): 137-147
Franke, G. 1972: Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease Therapie der Gegenwart 111(12): 1780 Passim
Kullich, W.; Fromme, K.; Klein, G. 1996: Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases Wiener Medizinische Wochenschrift 146(17): 459-464
Rhein, E.; Wenig, A. 1970: Clinical experiences in the treatment of rheumatic and non-rheumatic infectious diseases with an antiphlogistic agents Zeitschrift für Allgemeinmedizin 46(29): 1464-1466
Malinovskiĭ, N.N.; Golubev, I.S.; Tarichko, I.V. 1971: Use of ethacrynic acid in the surgical clinical aspects of patients with rheumatic heart diseases and circulatory insufficiency Sovetskaia Meditsina 34(4): 118-122
Morita, T.; Matsuyama, Y.; Higuchi, M. 1981: Clinical significance of bile acid tolerance tests in patients with liver diseases Rinsho Byori. Japanese Journal of Clinical Pathology 29(5): 467-470
Shinozaki, K. 1981: A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay Rinsho Byori. Japanese Journal of Clinical Pathology 29(5): 475-477
Vitali, G. 1980: Controlled clinical experiment with the topical use of 2-(3-benzoyl-phenyl) propionic acid at 3 different concentrations La Clinica Terapeutica 94(3): 257-273
Stern, M.P.; Kolterman, O.G.; Fries, J.F.; McDevitt, H.O.; Reaven, G.M. 1973: Adrenocortical steroid treatment of rheumatic diseases. Effects on lipid metabolism Archives of Internal Medicine 132(1): 97-101
Tsurumi, K.; Kokuba, S.; Okada, K.; Yanagihara, M.; Fujimura, H. 1986: Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis Arzneimittel-Forschung 36(12): 1810-1817
Spotorno, N.; Gulizzi, F.; Astengo, A. 1976: Colloid au 198 in the intra-articular treatment of chronic rheumatic diseases. our clinical experience La Clinica Terapeutica 77(6): 553-560
Ishimori, A.; Yamagata, S.; Taima, T. 1979: Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study Arzneimittel-Forschung 29(10): 1625-1632
Tsurumi, K.; Kyuki, K.; Niwa, M.; Mibu, H.; Fujimura, H. 1986: Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions Arzneimittel-Forschung 36(12): 1801-1805
Kononova, N.S.; Barko, A.I.; Navrotskiĭ, V.V.; Sokolov, B.A.; Siurin, S.A. 1982: Effect of the terrain cure on the tolerance for physical loading and on the lactic acid level of the blood in the combined treatment of chronic nonspecific lung diseases Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 54-56
Rådberg, T.; Gustafson, A.; Skryten, A.; Karlsson, K. 1982: Metabolic studies in gestational diabetic women during contraceptive treatment: effects on glucose tolerance and fatty acid composition of serum lipids Gynecologic and Obstetric Investigation 13(1): 17-29
Podhajna, E.; Kujawski, M.; Sańko, B.; Cichosz, G.; Butler, J. 2001: Synergistic and antagonistic properties of selected cultures of lactic acid and propionic acid bacteria. Part II. Proteolytic activity Mededelingen 66(3b): 617-620
Neumann, W.; Barthel, E.; Tanner, E.; Seidel, K. 1970: Gm-properties in rheumatic diseases with reference to chronic progressive polyarthritis. I. Gm(a) and Gm(x) factors in rheumatic diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(7): 308-311
Svintsitskiĭ, A.S.; Iakovlev, A.A.; Belikova, N.N.; Kostenko, E.V. 1991: The characteristics of acid-formation regulation in the stomach of patients with rheumatic diseases Vrachebnoe Delo 4: 37-40